184 related articles for article (PubMed ID: 4058458)
1. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
Griggs RC; Mendell JR; Brooke MH; Fenichel GM; Miller JP; Province M; Moxley RT; Huntzinger D; Vaughn A; Cohen M
Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
[TBL] [Abstract][Full Text] [Related]
2. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection.
Percy ME; Chang LS; Murphy EG; Oss I; Verellen-Dumoulin C; Thompson MW
Muscle Nerve; 1979; 2(5):329-39. PubMed ID: 492209
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
Zatz M; Otto PA
Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
[TBL] [Abstract][Full Text] [Related]
4. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
Passos MR; Gonzalez CH; Zatz M
Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
[TBL] [Abstract][Full Text] [Related]
5. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
Percy ME; Andrews DF; Thompson MW
Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
[TBL] [Abstract][Full Text] [Related]
6. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
Muir WA; Knoke J; Martin A; Vignos P; McErlean A
Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
Zatz M; Karp LE; Rogatko A
Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
[TBL] [Abstract][Full Text] [Related]
8. Genetic and environmental components of serum creatine kinase (CK) and pyruvate kinase (PK) in normal twins: implication for genetic risks estimates in Duchenne muscular dystrophy carriers.
Rapaport D; Colletto GM; Zatz M
Am J Med Genet; 1988 Oct; 31(2):291-8. PubMed ID: 3232697
[TBL] [Abstract][Full Text] [Related]
9. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase, hemopexin, pyruvate kinase, and lactate dehydrogenase in combination.
Percy ME; Andrews DF; Thompson MW
Am J Med Genet; 1982 Sep; 13(1):27-38. PubMed ID: 7137219
[TBL] [Abstract][Full Text] [Related]
10. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
Zatz M; Passos MR; Bortolini ER
Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
[No Abstract] [Full Text] [Related]
11. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
[TBL] [Abstract][Full Text] [Related]
12. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs.
Passos MR; Zatz M
Am J Med Genet; 1983 Nov; 16(3):367-72. PubMed ID: 6650572
[TBL] [Abstract][Full Text] [Related]
13. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
[TBL] [Abstract][Full Text] [Related]
15. Plasma pyruvate kinase and creatine kinase activity in Becker muscular dystrophy.
Aston JP; Kingston HM; Ramasamy I; Walters EG; Stansbie D
J Neurol Sci; 1984 Sep; 65(3):307-14. PubMed ID: 6491692
[TBL] [Abstract][Full Text] [Related]
16. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
Passos-Bueno MR; Otto PA; Zata M
Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
[TBL] [Abstract][Full Text] [Related]
17. Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy.
Ionasescu V; Burmeister L; Hanson J
Am J Med Genet; 1980; 5(1):5-12. PubMed ID: 7395900
[TBL] [Abstract][Full Text] [Related]
18. Making the most of multiple measurements in estimating carrier probability in Duchenne muscular dystrophy: the Bayesian incorporation of repeated measurements using logistic discrimination.
Percy ME; Andrews DF; Brasher PM; Rusk AC
Am J Med Genet; 1987 Apr; 26(4):851-61. PubMed ID: 3591827
[TBL] [Abstract][Full Text] [Related]
19. The importance of serum pyruvate kinase in neuromuscular diseases and carrier states.
Sage J; Inati Y; Samaha F
Muscle Nerve; 1979; 2(5):390-3. PubMed ID: 492215
[TBL] [Abstract][Full Text] [Related]
20. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
